Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2002;105:1850-1856
Published online before print April 8, 2002, doi: 10.1161/01.CIR.0000014211.47830.4D
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
105/15/1850    most recent
01.CIR.0000014211.47830.4Dv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sah, R.
Right arrow Articles by Backx, P. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sah, R.
Right arrow Articles by Backx, P. H.
Related Collections
Right arrow Contractile function
Right arrow Congestive
Right arrow Animal models of human disease
Right arrow Hypertrophy
Right arrow Physiological and pathological control of gene expression

(Circulation. 2002;105:1850.)
© 2002 American Heart Association, Inc.


Basic Science Reports

Inhibition of Calcineurin and Sarcolemmal Ca2+ Influx Protects Cardiac Morphology and Ventricular Function in Kv4.2N Transgenic Mice

Rajan Sah, PhD; Gavin Y. Oudit, MSc, MD; The-Tin T. Nguyen, MSc; Hae W. Lim, PhD; Alan D. Wickenden, PhD; Gregory J. Wilson, MD; Jeffery D. Molkentin, PhD; Peter H. Backx, DVM, PhD

From the Departments of Physiology and Medicine and the Division of Cardiology, University Health Network, University of Toronto, Toronto, Canada (R.S., G.Y.O., T.-T.T.N., P.H.B.); the Department of Pediatrics, University of Cincinnati, Children’s Hospital Medical Center, Cincinnati, Ohio (H.W.L., J.D.M.); ICAgen Inc, Durham, NC (A.D.W.); and the Divisions of Cardiovascular Research and Pathology, Hospital for Sick Children, Toronto, and Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada (G.J.W.).

Correspondence to Peter H. Backx, DVM, PhD, Heart and Stroke/Richard Lewar Centre, Fitzgerald Building, Rm 68, 150 College St, Toronto, Ontario M55 3EZ, Canada. E-mail p.backx{at}utoronto.ca

Background Cardiac-targeted expression of truncated Kv4.2 subunit (Kv4.2N) reduces transient outward current (Ito) density, prolongs action potentials (APs), and enhances contractility in 3- to 4-week-old transgenic mice. By 13 to 15 weeks of age, these mice develop severely impaired cardiac function and signs of heart failure. In this study, we examined whether augmented contractility in Kv4.2N mice results from elevations in intracellular calcium ([Ca2+]i) secondary to AP prolongation and investigated the putative roles of calcineurin activation in heart disease development of Kv4.2N mice.

Methods and Results At 3 to 4 weeks of age, L-type Ca2+ influx and peak [Ca2+]i were significantly elevated in Kv4.2N myocytes compared with control because of AP prolongation. Cardiac calcineurin activity was also significantly elevated in Kv4.2N mice by 5 weeks of age relative to controls and increased progressively as heart disease developed. This was associated with activation of protein kinase C (PKC)-{alpha} and PKC-{theta} but not PKC-{epsilon}, as well as increases in ß-myosin heavy chain (ß-MHC) and reductions in sarcoplasmic/endoplasmic reticulum Ca2+-ATPase (SERCA)-2a expression. Treatment with either cyclosporin A or verapamil prevented increases in heart weight to body weight ratios, interstitial fibrosis, impaired contractility, PKC activation, and changes in the expression patterns of ß-MHC and SERCA2a.

Conclusions Our results demonstrate that AP prolongation caused by Ito reduction results in enhanced Ca2+ cycling and hypercontractility in mice and suggests that elevations in [Ca2+]i via ICa,L and activation of calcineurin play a central role in disease development after Ito reduction using the Kv4.2N construct.


Key Words: action potentials • contractility • cardiomyopathy • ion channels




This article has been cited by other articles:


Home page
HypertensionHome page
C. D. Garciarena, O. A. Pinilla, M. B. Nolly, R. P. Laguens, E. M. Escudero, H. E. Cingolani, and I. L. Ennis
Endurance Training in the Spontaneously Hypertensive Rat: Conversion of Pathological into Physiological Cardiac Hypertrophy
Hypertension, April 1, 2009; 53(4): 708 - 714.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
E. Schroder, J. Magyar, D. Burgess, D. Andres, and J. Satin
Chronic verapamil treatment remodels ICa,L in mouse ventricle
Am J Physiol Heart Circ Physiol, April 1, 2007; 292(4): H1906 - H1916.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. Funakoshi, T. O. Chan, J. C. Good, J. R. Libonati, J. Piuhola, X. Chen, S. M. MacDonnell, L. L. Lee, D. E. Herrmann, J. Zhang, et al.
Regulated Overexpression of the A1-Adenosine Receptor in Mice Results in Adverse but Reversible Changes in Cardiac Morphology and Function
Circulation, November 21, 2006; 114(21): 2240 - 2250.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
H. Sun, B.-G. Kerfant, D. Zhao, M. G. Trivieri, G. Y. Oudit, J. M. Penninger, and P. H. Backx
Insulin-Like Growth Factor-1 and PTEN Deletion Enhance Cardiac L-Type Ca2+ Currents via Increased PI3K{alpha}/PKB Signaling
Circ. Res., June 9, 2006; 98(11): 1390 - 1397.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
C. Fiset and W. R. Giles
Transmural Gradients of Repolarization and Excitation-Contraction Coupling in Mouse Ventricle
Circ. Res., May 26, 2006; 98(10): 1237 - 1239.
[Full Text] [PDF]


Home page
Circ. Res.Home page
W. Guo, W. E. Jung, C. Marionneau, F. Aimond, H. Xu, K. A. Yamada, T. L. Schwarz, S. Demolombe, and J. M. Nerbonne
Targeted Deletion of Kv4.2 Eliminates Ito,f and Results in Electrical and Molecular Remodeling, With No Evidence of Ventricular Hypertrophy or Myocardial Dysfunction
Circ. Res., December 9, 2005; 97(12): 1342 - 1350.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
B.-G. Kerfant, D. Gidrewicz, H. Sun, G. Y. Oudit, J. M. Penninger, and P. H. Backx
Cardiac Sarcoplasmic Reticulum Calcium Release and Load Are Enhanced by Subcellular cAMP Elevations in PI3K{gamma}-Deficient Mice
Circ. Res., May 27, 2005; 96(10): 1079 - 1086.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
T. Volk, P. J. Noble, M. Wagner, D. Noble, and H. Ehmke
Ascending aortic stenosis selectively increases action potential-induced Ca2+ influx in epicardial myocytes of the rat left ventricle
Exp Physiol, January 1, 2005; 90(1): 111 - 121.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. Lebeche, R. Kaprielian, F. del Monte, G. Tomaselli, J. K. Gwathmey, A. Schwartz, and R. J. Hajjar
In Vivo Cardiac Gene Transfer of Kv4.3 Abrogates the Hypertrophic Response in Rats After Aortic Stenosis
Circulation, November 30, 2004; 110(22): 3435 - 3443.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
Y. Wakisaka, S. Niwano, H. Niwano, J. Saito, T. Yoshida, S. Hirasawa, H. Kawada, and T. Izumi
Structural and electrical ventricular remodeling in rat acute myocarditis and subsequent heart failure
Cardiovasc Res, September 1, 2004; 63(4): 689 - 699.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
S. G. Birnbaum, A. W. Varga, L.-L. Yuan, A. E. Anderson, J. D. Sweatt, and L. A. Schrader
Structure and Function of Kv4-Family Transient Potassium Channels
Physiol Rev, July 1, 2004; 84(3): 803 - 833.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
C. F. Rossow, E. Minami, E. G. Chase, C. E. Murry, and L.F. Santana
NFATc3-Induced Reductions in Voltage-Gated K+ Currents After Myocardial Infarction
Circ. Res., May 28, 2004; 94(10): 1340 - 1350.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. B. Vega, R. Bassel-Duby, and E. N. Olson
Control of Cardiac Growth and Function by Calcineurin Signaling
J. Biol. Chem., September 26, 2003; 278(39): 36981 - 36984.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
I. Bodi, J. N. Muth, H. S. Hahn, N. N. Petrashevskaya, M. Rubio, S. E. Koch, G. Varadi, and A. Schwartz
Electrical remodeling in hearts from a calcium-dependent mouse model of hypertrophy and failure: Complex nature of k+ current changes and action potential duration
J. Am. Coll. Cardiol., May 7, 2003; 41(9): 1611 - 1622.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
R. Sah, R. J Ramirez, G. Y Oudit, D. Gidrewicz, M. G Trivieri, C. Zobel, and P. H Backx
Regulation of cardiac excitation-contraction coupling by action potential repolarization: role of the transient outward potassium current (Ito)
J. Physiol., January 1, 2003; 546(1): 5 - 18.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. Zobel, Z. Kassiri, T.-T. T. Nguyen, Y. Meng, and P. H. Backx
Prevention of Hypertrophy by Overexpression of Kv4.2 in Cultured Neonatal Cardiomyocytes
Circulation, October 29, 2002; 106(18): 2385 - 2391.
[Abstract] [Full Text] [PDF]